{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7383,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de076-4a3e-76ed-83f8-e348223f91d9",
      "docSlug": "c1eecdcf261eded4e99ffa840c30e475",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 60 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 44,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The slide uses a bar chart to compare two groups of drugs and their associated companies.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4a3e-76ed-83f8-e348223f91d9/44",
      "deckHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9",
      "deckAnchorHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9#slide-44",
      "loopMatches": [
        {
          "to": 60,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "50c25ad2-0c48-4213-947d-b362da490be1",
          "evidence": "The deck presents a 'why' (N-GENIUS platform), 'how' (technology overview), and 'what' (clinical results) narrative",
          "position": 1,
          "objective": "Why is Immix Biopharma's N-GENIUS platform important?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4a3e-76ed-83f8-e348223f91d9",
      "docSlug": "c1eecdcf261eded4e99ffa840c30e475",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 60 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 45,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Slide presents three distinct preclinical data sets: survival in STS mice, tumor response in STS mice, and survival in KPC pancreatic cancer mice.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4a3e-76ed-83f8-e348223f91d9/45",
      "deckHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9",
      "deckAnchorHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9#slide-45",
      "loopMatches": [
        {
          "to": 60,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "50c25ad2-0c48-4213-947d-b362da490be1",
          "evidence": "The deck presents a 'why' (N-GENIUS platform), 'how' (technology overview), and 'what' (clinical results) narrative",
          "position": 1,
          "objective": "Why is Immix Biopharma's N-GENIUS platform important?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4a3e-76ed-83f8-e348223f91d9",
      "docSlug": "c1eecdcf261eded4e99ffa840c30e475",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 60 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 46,
      "slideType": "other",
      "function": "illustrate_case",
      "notes": "Includes a process flow diagram illustrating the mechanism of action of IMX-110 in tumor microenvironments.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4a3e-76ed-83f8-e348223f91d9/46",
      "deckHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9",
      "deckAnchorHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9#slide-46",
      "loopMatches": [
        {
          "to": 60,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "50c25ad2-0c48-4213-947d-b362da490be1",
          "evidence": "The deck presents a 'why' (N-GENIUS platform), 'how' (technology overview), and 'what' (clinical results) narrative",
          "position": 1,
          "objective": "Why is Immix Biopharma's N-GENIUS platform important?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4a3e-76ed-83f8-e348223f91d9",
      "docSlug": "c1eecdcf261eded4e99ffa840c30e475",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 60 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 47,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes Kaplan-Meier survival curves and bioluminescence imaging of tumor activity.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4a3e-76ed-83f8-e348223f91d9/47",
      "deckHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9",
      "deckAnchorHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9#slide-47",
      "loopMatches": [
        {
          "to": 60,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "50c25ad2-0c48-4213-947d-b362da490be1",
          "evidence": "The deck presents a 'why' (N-GENIUS platform), 'how' (technology overview), and 'what' (clinical results) narrative",
          "position": 1,
          "objective": "Why is Immix Biopharma's N-GENIUS platform important?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4a3e-76ed-83f8-e348223f91d9",
      "docSlug": "c1eecdcf261eded4e99ffa840c30e475",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 60 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 48,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes waterfall and spider/line plots for patient response data.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4a3e-76ed-83f8-e348223f91d9/48",
      "deckHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9",
      "deckAnchorHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9#slide-48",
      "loopMatches": [
        {
          "to": 60,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "50c25ad2-0c48-4213-947d-b362da490be1",
          "evidence": "The deck presents a 'why' (N-GENIUS platform), 'how' (technology overview), and 'what' (clinical results) narrative",
          "position": 1,
          "objective": "Why is Immix Biopharma's N-GENIUS platform important?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4a3e-76ed-83f8-e348223f91d9",
      "docSlug": "c1eecdcf261eded4e99ffa840c30e475",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 60 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 49,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The slide uses a bubble chart to map clinical trials and a table to detail drug performance metrics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4a3e-76ed-83f8-e348223f91d9/49",
      "deckHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9",
      "deckAnchorHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9#slide-49",
      "loopMatches": [
        {
          "to": 60,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "50c25ad2-0c48-4213-947d-b362da490be1",
          "evidence": "The deck presents a 'why' (N-GENIUS platform), 'how' (technology overview), and 'what' (clinical results) narrative",
          "position": 1,
          "objective": "Why is Immix Biopharma's N-GENIUS platform important?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4a3e-76ed-83f8-e348223f91d9",
      "docSlug": "c1eecdcf261eded4e99ffa840c30e475",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 60 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 50,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a combination of a conceptual chart and a data table to demonstrate efficacy in heavily pre-treated patients.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4a3e-76ed-83f8-e348223f91d9/50",
      "deckHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9",
      "deckAnchorHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9#slide-50",
      "loopMatches": [
        {
          "to": 60,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "50c25ad2-0c48-4213-947d-b362da490be1",
          "evidence": "The deck presents a 'why' (N-GENIUS platform), 'how' (technology overview), and 'what' (clinical results) narrative",
          "position": 1,
          "objective": "Why is Immix Biopharma's N-GENIUS platform important?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4a3e-76ed-83f8-e348223f91d9",
      "docSlug": "c1eecdcf261eded4e99ffa840c30e475",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 60 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 51,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a process flow diagram to illustrate the clinical development path for two different treatment regimens.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4a3e-76ed-83f8-e348223f91d9/51",
      "deckHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9",
      "deckAnchorHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9#slide-51",
      "loopMatches": [
        {
          "to": 60,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "50c25ad2-0c48-4213-947d-b362da490be1",
          "evidence": "The deck presents a 'why' (N-GENIUS platform), 'how' (technology overview), and 'what' (clinical results) narrative",
          "position": 1,
          "objective": "Why is Immix Biopharma's N-GENIUS platform important?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4a3e-76ed-83f8-e348223f91d9",
      "docSlug": "c1eecdcf261eded4e99ffa840c30e475",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 60 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 52,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes a comparative diagram of the drug molecule vs standard IgG antibody and multiple clinical/preclinical data charts.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4a3e-76ed-83f8-e348223f91d9/52",
      "deckHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9",
      "deckAnchorHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9#slide-52",
      "loopMatches": [
        {
          "to": 60,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "50c25ad2-0c48-4213-947d-b362da490be1",
          "evidence": "The deck presents a 'why' (N-GENIUS platform), 'how' (technology overview), and 'what' (clinical results) narrative",
          "position": 1,
          "objective": "Why is Immix Biopharma's N-GENIUS platform important?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4a3e-76ed-83f8-e348223f91d9",
      "docSlug": "c1eecdcf261eded4e99ffa840c30e475",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 60 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 53,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes two sets of charts: tumor volume line graphs and survival curves for MDA-MB-231 and HCT-116 models.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4a3e-76ed-83f8-e348223f91d9/53",
      "deckHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9",
      "deckAnchorHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9#slide-53",
      "loopMatches": [
        {
          "to": 60,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "50c25ad2-0c48-4213-947d-b362da490be1",
          "evidence": "The deck presents a 'why' (N-GENIUS platform), 'how' (technology overview), and 'what' (clinical results) narrative",
          "position": 1,
          "objective": "Why is Immix Biopharma's N-GENIUS platform important?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4a3e-76ed-83f8-e348223f91d9",
      "docSlug": "c1eecdcf261eded4e99ffa840c30e475",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 60 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 54,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes detailed scientific diagrams of the drug mechanism and clinical trial results.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4a3e-76ed-83f8-e348223f91d9/54",
      "deckHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9",
      "deckAnchorHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9#slide-54",
      "loopMatches": [
        {
          "to": 60,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "50c25ad2-0c48-4213-947d-b362da490be1",
          "evidence": "The deck presents a 'why' (N-GENIUS platform), 'how' (technology overview), and 'what' (clinical results) narrative",
          "position": 1,
          "objective": "Why is Immix Biopharma's N-GENIUS platform important?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4a3e-76ed-83f8-e348223f91d9",
      "docSlug": "c1eecdcf261eded4e99ffa840c30e475",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 60 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 55,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a bar chart comparison to highlight the efficacy gap between established treatments and placebo.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4a3e-76ed-83f8-e348223f91d9/55",
      "deckHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9",
      "deckAnchorHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9#slide-55",
      "loopMatches": [
        {
          "to": 60,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "50c25ad2-0c48-4213-947d-b362da490be1",
          "evidence": "The deck presents a 'why' (N-GENIUS platform), 'how' (technology overview), and 'what' (clinical results) narrative",
          "position": 1,
          "objective": "Why is Immix Biopharma's N-GENIUS platform important?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4a3e-76ed-83f8-e348223f91d9",
      "docSlug": "c1eecdcf261eded4e99ffa840c30e475",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 60 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 56,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a side-by-side comparison of two proprietary technology platforms.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4a3e-76ed-83f8-e348223f91d9/56",
      "deckHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9",
      "deckAnchorHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9#slide-56",
      "loopMatches": [
        {
          "to": 60,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "50c25ad2-0c48-4213-947d-b362da490be1",
          "evidence": "The deck presents a 'why' (N-GENIUS platform), 'how' (technology overview), and 'what' (clinical results) narrative",
          "position": 1,
          "objective": "Why is Immix Biopharma's N-GENIUS platform important?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4a3e-76ed-83f8-e348223f91d9",
      "docSlug": "c1eecdcf261eded4e99ffa840c30e475",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 60 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 57,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a process-flow style layout to connect platform capabilities to specific product outcomes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4a3e-76ed-83f8-e348223f91d9/57",
      "deckHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9",
      "deckAnchorHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9#slide-57",
      "loopMatches": [
        {
          "to": 60,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "50c25ad2-0c48-4213-947d-b362da490be1",
          "evidence": "The deck presents a 'why' (N-GENIUS platform), 'how' (technology overview), and 'what' (clinical results) narrative",
          "position": 1,
          "objective": "Why is Immix Biopharma's N-GENIUS platform important?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4a3e-76ed-83f8-e348223f91d9",
      "docSlug": "c1eecdcf261eded4e99ffa840c30e475",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 60 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 58,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a serpentine process flow (1-5 left-to-right, 6-10 right-to-left).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4a3e-76ed-83f8-e348223f91d9/58",
      "deckHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9",
      "deckAnchorHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9#slide-58",
      "loopMatches": [
        {
          "to": 60,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "50c25ad2-0c48-4213-947d-b362da490be1",
          "evidence": "The deck presents a 'why' (N-GENIUS platform), 'how' (technology overview), and 'what' (clinical results) narrative",
          "position": 1,
          "objective": "Why is Immix Biopharma's N-GENIUS platform important?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4a3e-76ed-83f8-e348223f91d9",
      "docSlug": "c1eecdcf261eded4e99ffa840c30e475",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 60 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 59,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a process-like flow from the 3 pillars to the specific product outcomes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4a3e-76ed-83f8-e348223f91d9/59",
      "deckHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9",
      "deckAnchorHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9#slide-59",
      "loopMatches": [
        {
          "to": 60,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "50c25ad2-0c48-4213-947d-b362da490be1",
          "evidence": "The deck presents a 'why' (N-GENIUS platform), 'how' (technology overview), and 'what' (clinical results) narrative",
          "position": 1,
          "objective": "Why is Immix Biopharma's N-GENIUS platform important?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4a3e-76ed-83f8-e348223f91d9",
      "docSlug": "c1eecdcf261eded4e99ffa840c30e475",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 60 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 60,
      "slideType": "cover",
      "function": "front_matter",
      "notes": "Includes date and ticker symbol.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4a3e-76ed-83f8-e348223f91d9/60",
      "deckHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9",
      "deckAnchorHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9#slide-60",
      "loopMatches": [
        {
          "to": 60,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "50c25ad2-0c48-4213-947d-b362da490be1",
          "evidence": "The deck presents a 'why' (N-GENIUS platform), 'how' (technology overview), and 'what' (clinical results) narrative",
          "position": 1,
          "objective": "Why is Immix Biopharma's N-GENIUS platform important?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/6M1kLlDf6aUtjUIztbI9oMwJUQA8i0LFwlfx6acEkIA/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jMjQxYWM5ZWRkMjQ0MzQ1MjI1Nzk0OWNlMGE3M2Q2NS9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/1",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 3,
          "from": 1,
          "beatId": "cfa0c1bd-b8ce-4ae0-b88d-4c0c279158ba",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Attention",
          "beatSlug": "aida-attention",
          "evidence": "The deck starts with a cover slide, disclaimer, and executive summary highlighting key points",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Hook",
          "parentBeatSlug": "hook"
        }
      ],
      "imagePathAlt": "https://imgproxy.kitesheet.com/4EGsxIdAySQwMOmgUj0a2ww7dNyFy3dgxu7a5daZOMc/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jMjQxYWM5ZWRkMjQ0MzQ1MjI1Nzk0OWNlMGE3M2Q2NS9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/e-gmlWg0zwX2ff0wQrl4e8uJyP1ZRJ744CIeHk4WHI0/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jMjQxYWM5ZWRkMjQ0MzQ1MjI1Nzk0OWNlMGE3M2Q2NS9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/dc7QwUEwkzv8cwPeZLV2mMF6s1eQlV8uCxzTnFPAt7o/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jMjQxYWM5ZWRkMjQ0MzQ1MjI1Nzk0OWNlMGE3M2Q2NS9wMDAxLnBuZw"
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/2",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 3,
          "from": 1,
          "beatId": "cfa0c1bd-b8ce-4ae0-b88d-4c0c279158ba",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Attention",
          "beatSlug": "aida-attention",
          "evidence": "The deck starts with a cover slide, disclaimer, and executive summary highlighting key points",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Hook",
          "parentBeatSlug": "hook"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": "The slide uses a numbered list format to present key value propositions.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/3",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 3,
          "from": 1,
          "beatId": "cfa0c1bd-b8ce-4ae0-b88d-4c0c279158ba",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Attention",
          "beatSlug": "aida-attention",
          "evidence": "The deck starts with a cover slide, disclaimer, and executive summary highlighting key points",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Hook",
          "parentBeatSlug": "hook"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide uses a grid-based layout to categorize team members into three distinct groups: Leadership, Board of Directors, and Scientific Advisory Board.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/4",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 4,
          "beatId": "7719616c-f553-44bf-8bfe-cc092ccfc183",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The team bio, solution overview, and N-GENIUS platform details generate interest",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a causal-chain framework to link platform capabilities to strategic outcomes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/5",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 4,
          "beatId": "7719616c-f553-44bf-8bfe-cc092ccfc183",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The team bio, solution overview, and N-GENIUS platform details generate interest",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "pain_points",
      "function": "frame_problem",
      "notes": "Uses a hub-and-spoke diagram to illustrate the negative impacts of a central problem.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/6",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-6",
      "loopMatches": [
        {
          "to": 9,
          "from": 6,
          "name": "Logic Chain",
          "slug": "01-logic-chain",
          "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
          "matchId": "2a731b3e-52c5-46a2-b542-abdc9832fb4b",
          "evidence": "The deck logically connects the platform's components to its advantages",
          "position": 0,
          "objective": "Explain the N-GENIUS platform technology",
          "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
          "confidence": 0.8,
          "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 4,
          "beatId": "7719616c-f553-44bf-8bfe-cc092ccfc183",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The team bio, solution overview, and N-GENIUS platform details generate interest",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a structural diagram to highlight the substitution of the 'Tumor Binding Domain' with the 'COBRA Binder' in the NXC-201 molecule.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/7",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-7",
      "loopMatches": [
        {
          "to": 9,
          "from": 6,
          "name": "Logic Chain",
          "slug": "01-logic-chain",
          "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
          "matchId": "2a731b3e-52c5-46a2-b542-abdc9832fb4b",
          "evidence": "The deck logically connects the platform's components to its advantages",
          "position": 0,
          "objective": "Explain the N-GENIUS platform technology",
          "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
          "confidence": 0.8,
          "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 4,
          "beatId": "7719616c-f553-44bf-8bfe-cc092ccfc183",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The team bio, solution overview, and N-GENIUS platform details generate interest",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a schematic diagram to map specific protein domains to their functional benefits.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/8",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-8",
      "loopMatches": [
        {
          "to": 9,
          "from": 6,
          "name": "Logic Chain",
          "slug": "01-logic-chain",
          "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
          "matchId": "2a731b3e-52c5-46a2-b542-abdc9832fb4b",
          "evidence": "The deck logically connects the platform's components to its advantages",
          "position": 0,
          "objective": "Explain the N-GENIUS platform technology",
          "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
          "confidence": 0.8,
          "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 4,
          "beatId": "7719616c-f553-44bf-8bfe-cc092ccfc183",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The team bio, solution overview, and N-GENIUS platform details generate interest",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses academic citations to validate the mechanism of action for their CAR-T design.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/9",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-9",
      "loopMatches": [
        {
          "to": 9,
          "from": 6,
          "name": "Logic Chain",
          "slug": "01-logic-chain",
          "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
          "matchId": "2a731b3e-52c5-46a2-b542-abdc9832fb4b",
          "evidence": "The deck logically connects the platform's components to its advantages",
          "position": 0,
          "objective": "Explain the N-GENIUS platform technology",
          "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
          "confidence": 0.8,
          "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 4,
          "beatId": "7719616c-f553-44bf-8bfe-cc092ccfc183",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The team bio, solution overview, and N-GENIUS platform details generate interest",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a combination of bar charts for preclinical cytokine release and a table for clinical outcomes to demonstrate the superiority of NXC-201.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/10",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-10",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 10,
          "beatId": "7f3ecbba-6032-4531-bb7e-529e9174ab66",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The competitive analysis, solution advantages, and clinical data create desire for the technology",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide compares HSL (Heavy-chain-led) vs LSH (Light-chain-led) configurations using bar charts for expansion and cytotoxicity metrics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/11",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 10,
          "beatId": "7f3ecbba-6032-4531-bb7e-529e9174ab66",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The competitive analysis, solution advantages, and clinical data create desire for the technology",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes a cartoon character graphic at the bottom.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/12",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 10,
          "beatId": "7f3ecbba-6032-4531-bb7e-529e9174ab66",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The competitive analysis, solution advantages, and clinical data create desire for the technology",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a bar chart combined with a data table to highlight safety advantages. It includes a disclaimer about cross-trial comparisons.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/13",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 10,
          "beatId": "7f3ecbba-6032-4531-bb7e-529e9174ab66",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The competitive analysis, solution advantages, and clinical data create desire for the technology",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}